Cargando…

Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial

BACKGROUND: Oral anticoagulation therapy is recommended for the prevention of recurrent ischemic stroke in patients with atrial fibrillation (AF). Current guidelines do not provide evidence-based recommendations on optimal time-point to start anticoagulation therapy after an acute ischemic stroke. N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Åsberg, Signild, Hijazi, Ziad, Norrving, Bo, Terént, Andreas, Öhagen, Patrik, Oldgren, Jonas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712199/ https://www.ncbi.nlm.nih.gov/pubmed/29197413 http://dx.doi.org/10.1186/s13063-017-2313-9

Ejemplares similares

Early Versus Delayed Non–Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study
por: Oldgren, Jonas, et al.
Publicado: (2022)

Risk of ischemic stroke and utility of CHA(2)DS(2)‐VASc score in women and men with atrial fibrillation
por: Tomasdottir, Maria, et al.
Publicado: (2019)

Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation
por: Hijazi, Ziad, et al.
Publicado: (2020)

Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation
por: Meinel, Thomas R., et al.
Publicado: (2020)

ABC-AF-Stroke score predicts thromboembolism in non-anticoagulated patients following successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry
por: Wang, Yufeng, et al.
Publicado: (2023)

Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation
por: Galea, Roberto, et al.
Publicado: (2023)

Efficacy and safety of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation
por: Friberg, Leif, et al.
Publicado: (2017)

Etiology of Ischemic Strokes of Patients with Atrial Fibrillation and Therapy with Anticoagulants
por: Purrucker, Jan C., et al.
Publicado: (2020)

Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
por: Tiili, Paula, et al.
Publicado: (2021)

Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation
por: Seiffge, David J., et al.
Publicado: (2020)

Oral Anticoagulation Timing in Patients with Acute Ischemic Stroke and Atrial Fibrillation
por: Chang, Po-Yin, et al.
Publicado: (2021)

Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation
por: Hijazi, Ziad, et al.
Publicado: (2022)

Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time
por: Hijazi, Ziad, et al.
Publicado: (2017)

Factors Associated with Ischemic Stroke on Therapeutic Anticoagulation in Patients with Nonvalvular Atrial Fibrillation
por: Kim, Young Dae, et al.
Publicado: (2015)

Undertreatment of Anticoagulant Therapy in Hospitalized Acute Ischemic Stroke Patients With Atrial Fibrillation
por: Gong, Xiaoxian, et al.
Publicado: (2022)

Protocol for LASER: A Randomized Evaluation and an Associated Registry of Early Anticoagulation With Edoxaban After Ischemic Stroke in Patients With Atrial Fibrillation
por: Alrohimi, Anas, et al.
Publicado: (2021)

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation
por: Hijazi, Ziad, et al.
Publicado: (2016)

An international longitudinal registry of patients with atrial fibrillation at risk of stroke (GARFIELD): the UK protocol
por: Apenteng, Patricia N, et al.
Publicado: (2013)

Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF)
por: Sun, Yihong, et al.
Publicado: (2019)

Non-vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: A retrospective register study
por: Sjögren, Vilhelm, et al.
Publicado: (2017)

Hypertension prevalence but not control varies across the spectrum of risk in patients with atrial fibrillation: A RE-LY atrial fibrillation registry sub-study
por: McAlister, Finlay A., et al.
Publicado: (2020)

Ischemic Stroke Risk Factors in Patients with Atrial Fibrillation Treated with New Oral Anticoagulants
por: Wańkowicz, Paweł, et al.
Publicado: (2021)

Predictors for Stroke and Death in Non-Anticoagulated Asian Patients with Atrial Fibrillation: The Fushimi AF Registry
por: Hamatani, Yasuhiro, et al.
Publicado: (2015)

AUtomated Risk Assessment for Stroke in Atrial Fibrillation (AURAS-AF) - an automated software system to promote anticoagulation and reduce stroke risk: study protocol for a cluster randomised controlled trial
por: Holt, Tim A, et al.
Publicado: (2013)

Rationale and design of the Chinese Atrial Fibrillation Registry Study
por: Du, Xin, et al.
Publicado: (2016)

Impact of type of oral anticoagulants in patients with cerebral microbleeds after atrial fibrillation-related ischemic stroke or TIA: Results of the NOACISP-LONGTERM registry
por: Wagner, Benjamin, et al.
Publicado: (2022)

Use of oral anticoagulants and its associated factors among nonvalvular atrial fibrillation patients with new‐onset acute ischemic stroke: A report from the China Atrial Fibrillation Registry study
por: Wang, Jing‐Rong, et al.
Publicado: (2021)

Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials
por: Hijazi, Ziad, et al.
Publicado: (2020)

Anticoagulation versus Antiplatelet Therapy after Ischemic Stroke in the Patients with Atrial Fibrillation and Cerebral Microbleeds
por: Choi, Kang-Ho, et al.
Publicado: (2021)

Evaluation of the timing of using direct oral anticoagulants after ischemic stroke for patients with atrial fibrillation
por: Yu, Hui-Tzu, et al.
Publicado: (2023)

Use of Oral Anticoagulation Therapy in Atrial Fibrillation after Stroke: Results from a Nationwide Registry
por: Jespersen, Stine Funder, et al.
Publicado: (2013)

Anticoagulation therapy in patients with stroke and atrial fibrillation: a registry-based study of acute stroke care in Surrey, UK
por: Han, Thang S, et al.
Publicado: (2018)

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
por: Turpie, Alexander GG
Publicado: (2014)

Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
por: Schäfer, Andreas, et al.
Publicado: (2020)

Atrial fibrillation, electroconvulsive therapy, stroke risk, and anticoagulation
por: Kapadia, Meera, et al.
Publicado: (2023)

Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial
por: Pol, Tymon, et al.
Publicado: (2018)

Why Did All Patients with Atrial Fibrillation and High Risk of Stroke Not Receive Oral Anticoagulants? Results of the Polish Atrial Fibrillation (POL-AF) Registry
por: Szpotowicz, Anna, et al.
Publicado: (2021)

The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF): Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands
por: ten Cate, V., et al.
Publicado: (2016)

Plasma angiopoietin-2 and its association with heart failure in patients with atrial fibrillation
por: Benz, Alexander P, et al.
Publicado: (2023)

Prognostic Value of International Normalized Ratio in Ischemic Stroke Patients without Atrial Fibrillation or Anticoagulation Therapy
por: Xie, Xuewei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dkeocqgul1pov0cjdjdc4jpjik